Annual Drug Patent Expirations for INVELTYS
Inveltys is a drug marketed by Kala Pharms Inc and is included in one NDA. There are eight patents protecting this drug.
This drug has sixty-four patent family members in twelve countries.
The generic ingredient in INVELTYS is loteprednol etabonate. Additional details are available on the loteprednol etabonate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
